Blood Care Awareness – What are leukaemia, lymphoma and myeloma? Get informed here!


Blood Cancer Awareness

Blood Cancer Awareness

Doctors to be offered online training to improve UK’s poor diagnosis rates for blood cancers

• A new training course has been developed by blood cancer support charity Leukaemia CARE, in collaboration with the Royal College of General Practitioners (RCGP), and launched to mark the start of Blood Cancer Awareness Month

• The course set to radically improve GP knowledge of blood cancer symptoms, potentially saving around 1,000 lives a year

• Blood cancer survival from GP referral stands at 83.6% – but falls to 53.1% if diagnosis is delayed until the emergency admissions route.

• However, blood cancer symptoms can be easily confused with the symptoms of other less serious illnesses like the flu, leading to 33% of blood cancers – more than 10,000 patients – only diagnosed via emergency admissions

• Blood cancers such as leukaemia, lymphoma and myeloma are statistically the nation’s fifth largest cancer threat with 34,000 people diagnosed each year, and are the third biggest cancer killer

A new online training course designed to raise awareness of the symptoms of blood cancer among GPs is set to radically improve the rate of early diagnosis, bringing the UK up to EU standards and potentially saving around 1,000 lives a year.

Blood cancer support charity Leukaemia CARE, in collaboration with the Royal College of General Practitioners (RCGP), has developed the course in a bid to deliver better outcomes for the 34,000 people diagnosed with blood cancers in the UK each year.


When combined, blood cancers like leukaemia, lymphoma and myeloma are statistically the nation’s fifth largest cancer threat and third biggest cancer killer. And yet because many of the symptoms of blood cancer experienced by patients, such as persistent fatigue, night sweats, joint pain, bruising and recurrent infections, may also be linked with a wide range of other less serious diseases, 33% of blood cancers – more than 10,000 patients – are only diagnosed via the emergency admissions route, including accident and emergency.

Research shows that early diagnosis has a major impact on survival rates. For instance, the one year survival rate for myeloma patients diagnosed following a GP referral stands at 83.6% – but falls to 53.1% if diagnosis is delayed until the emergency admissions route3.

While online courses for GPs are available for other major cancers, this is the first of its kind for all blood cancers. Free of charge, it combines information on how to recognise the symptoms with case studies and, like all RCGP training courses, carries Continuous Professional Development (CPD) points – which GPs must complete to demonstrate that they are meeting the standards set by the General Medical Council.

The news comes as the UK marks its third Blood Cancer Awareness Month (1-30 September).

We interview Tony Gavin the Director of Campaigning and Advocacy at Leukaemia CARE and Dr Ishani Patel who is a GP and the Royal College of General Practitioners (RCGP) Clinical Lead for Early Diagnosis of Cancer and Quality Improvement

Question – What is blood cancer?

Dr Ishani Patel

Dr Ishani Patel

Dr Ishani Patel – Blood cancer is an excessive growth of blood cells. For diseases such as lymphoma and leukaemia, this can be an excessive growth of white blood cells. The white blood cell is responsible for immunity and fighting off infection. However, when there is an overgrowth or an excessive amount of white cells, patients can often present with symptoms such as tiredness, excessive sweating, bone pains, bruising and bleeding. That’s a very brief overview of what a blood cancer is.

Question – How do leukaemia, lymphoma and myeloma differ from each other?

Tony Gavin – That is a huge question because within those disease areas there are also other disease types. There are 90 different leukaemias and 60 different lymphomas. There’s about 5 or 6 main types of myeloma, as well as other types, so we couldn’t really begin to describe the differences between them.

Collectively blood cancers are a huge problem in the UK and they are very poorly understood. At Leukaemia Care we think of them as a Cinderella disease, tucked away in the background with nobody fully aware of them, but blood cancers are the fourth largest notifiable cancer amongst men and women. Indeed if you look at the mortality rates and the people who die from blood cancer, more people die from blood cancer than die from breast cancer, more people die from blood cancer than die from prostate cancer. The sixth largest notifiable cancer in the UK is malignant melanoma (skin cancer). More people die from blood cancer than are actually diagnosed with skin cancer.
That’s how significant the problem is and that’s why we decided we needed to do something to help general practitioners recognise the signs and symptoms of the disease.

Question – What do the stages of different cancers mean?

Dr Ishani Patel – The different stages correspond with how much the disease has progressed.

For example in the context of blood cancers and the subset myeloma, if you present to the GP and are referred onto a specialist, your 1 year survival rate is 84% because you are diagnosed at an early stage, so stage 1.

However if you present as an emergency presentation, which is a third of all blood cancers, your 1 year survival rate drops to 55% so that’s a late stage diagnosis, which could be considered stage 3 or 4.

It’s difficult to drill into the detail of what each stage means because it’s obviously different depending on the type of blood cancer and as Tony’s just mentioned there are over 100 different types of blood cancers just within that terminology.

Question – What are the early signs and symptoms of blood cancers?

Dr Ishani Patel – Signs and symptoms to look out for include tiredness, excessive sweating, bone pain, bruising, bleeding, and recurrent infections. These can all present as individual signs or as a cluster of an early blood cancer. However if patients experience loss of appetite or weight loss, those are obviously signs of perhaps a cancer that has progressed.

Tony Gavin – With the lymphomas for instance you might have lumps in the neck or lumps in the armpit, or lumps in the groin. And the other thing to look out for is that quite a lot of the symptoms can be defined by something else. They could be just a common cold or flu or even menopause for the older patient. It’s when these signs and symptoms are persistent that you really need to take notice of them.

Question – Who treats these cancers and how?

Dr Ishani Patel – If we were to look at a classic patient journey, the GP who thinks there is a collection of symptoms that are causing concern would arrange for blood tests and perhaps a urine test or potentially even x-rays within primary care. They would arrange for what’s called a fast track cancer referral, which is a two-week-wait cancer referral where the patient can then be met by a haematologist. However, not all patients experience the same journey because of the varying ways that they present.

If a patient presents with, for example, a neck lump or a lump in their armpit or groin, they may go straight to a surgeon because they need to get a tissue sample or a biopsy to get a diagnosis.

However if a patient that presents with these symptoms then has a blood test and the blood test itself is abnormal, then they may be routed to a haematologist. Not everybody sees a haematologist straight away because it does very much depend on how they present in the first place.

Tony Gavin – The problem with bone pain is you would probably be referred to an orthopaedic surgeon before they realize it could be myeloma for instance. Within the blood cancer specialist community, within the haematology community, there are people that will specialise in leukaemias, lymphomas, and myelomas, and indeed within the leukaemias you may get people that specialise with chronic myeloid leukaemia, and those that specialize with acute myeloid leukaemia, so it varies. There are generalists and there are very, very specific specialists.

Question – How effective are the treatments?

Tony Gavin – That’s a really good question but a very difficult one to answer because you will find Tony Gavindifferent treatments for the whole range of different disease areas. I can quote one disease area where there is really, really good news. About 12 years ago survival rates for chronic myeloid leukaemia (CML) were poor. If you were diagnosed with CML in 2000 for instance then your survival prospects would be 3 – 5 years. In 2001 a new drug called Imatanib was developed – a tyrosine-kinase inhibitor. This class of drug has completely and utterly revolutionised the treatment of CML. Patients that respond to these drugs will not die from CML, they will not die from the leukaemia. This particular class of drugs is amazing, it’s one of the best good luck stories going around. It is a huge step change in the treatment of that particular disease.

Question – Please tell us about this new online tool, what it does and what its value will be.

Dr Ishani Patel – Leukaemia Care and the Royal College of General Practitioners have come together to develop a one hour learning course for not only GPs but all primary care health professionals. GPs are legally and professionally required to commit and evidence their own professional development i.e. the time they contribute to their own education. What Leukaemia Care has recognised is that the other cancers have a lot of attention both in the media and within GP education and we didn’t want blood cancers to be overlooked. So what this course does is provide case based scenarios almost like it is in real life. As a GP you’re sitting in your consultation room and a patient presents with a cluster of symptoms and it challenges the GP to think about what their next steps would be. For example if a patient presents with tiredness and with a lump in the neck what would they do next? And then once they have submitted their answers and evidenced their own reflection, it then takes them through to the gold standard and through the NICE guidelines on what they should do next, how to ensure rapid investigation and how to ensure that the patient’s route to diagnosis is as quick as possible.

Question – What one piece of advice would you give to someone who has just been diagnosed with a blood cancer?

Dr Ishani Patel – That’s a very tough question because there are different types of blood cancers. What I would say is that something that does get overlooked with all cancer treatments is nutrition. I would advise any patient going through or preparing to go through cancer treatments that could include steroids, chemotherapy, stem cell transplants and as Tony was saying tyrosine-kinase inhibitors that having a high protein diet and ensuring their nutrition is adequate will support them through their journey especially with managing the adverse effects of treatments. That would be my input from a GP perspective.

Tony Gavin – From my perspective, I would echo what Dr Patel has said but also say that they are not alone. They need to get in touch with a specialist organisation like Leukaemia Care, which can support them through their treatment. They can go online to leukaemiacare.org.uk and they can talk to our specialist nurse or talk to our care line experts. We have a care line that operates 24/7 so they can phone us at any time for help and advice and we can also put them in touch with patients who have been diagnosed with a similar disease so they can share their concerns and their worries. The other thing I have to say is there are breakthrough drugs coming through all the time in all the different disease areas and some of the new treatments coming through are superb. So first of all, don’t lose hope, get in touch with an organisation like Leukaemia Care and we’ll put you in touch with other groups too if you need to speak to somebody else.

We have a wealth of information online too and there’s lots that they can do to educate themselves on the disease.

Question – Where can people go for more information?

Dr Ishani Patel – Leukaemia Care provides robust information that is easy for patients to understand. From a GP perspective, I would encourage GPs to go to the Royal College of GPs website and do the online learning exercises to then be able to communicate that back to patients.

Tony Gavin – If patients do need more information once they have been in touch with Leukaemia Care, we can signpost them onto other areas.

What is Leukaemia? Read our frequently asked questions blog and find out about the ‘Call on Us’ campaign


Manos Nikolousis

Manos Nikolousis

A leading UK blood cancer charity is ringing the changes for how we seek help in times of need, urging people to avoid putting their mental health at risk by ditching screen support in favour of the telephone.

Leukaemia CARE has launched its ‘Call on Us’ campaign, which encourages patients, relatives and friends to pick up the phone and chat through how they are feeling about the impact of blood cancer on their lives, rather than relying on the internet.

The campaign comes after the charity noticed the number of calls to its Care Line drop by more than half in four years, despite 40,000 people being diagnosed each year with a blood cancer or allied blood disorder, with the commonest ones being leukaemia, lymphoma and myeloma.

However, with respondents to a poll1 admitting that they were kept awake at night by worries including whether they were going to die (54%), how quickly the disease would progress (63%), whether the disease would affect their quality of life (44%) and how their family will cope with their diagnosis (44%), experts at Leukaemia CARE say that it is only through verbal contact that those touched by cancer can have their fears properly allayed.

They are also concerned that the general public are using the internet to self-diagnose with 85% saying they have looked up symptoms online. As a result of doing this, 38% say the wrong diagnosis made them panic and stressed them out, 32% wished they had never done it as what they read on the internet made them feel they had something serious when they didn’t and 29% would never Google their symptoms again, concluding it’s much better to just go to the GP.


To show our support for ‘Call on Us’ campaign PatientTalk.Org conducted an interview with Esther Wroughton (care director at Leukaemia Care) and Manos Nikolousis who is consultant haematologist at Birmingham Heartlands Hospital.

Question: What is Leukaemia?

MANOS NIKOLOUSIS – Leukaemia is a form of blood cancer which mainly affects the bone marrow of the patients. Within the term ‘Leukaemia’ there are different sub groups. The word comes from the Greek word where ‘leuk’ is ‘white’ and ‘aemia’ is the blood. It is a cancer of the white blood cells.

Question – How is this different from Lymphoma?

MANOS NIKOLOUSIS – Lymphoma is considered a blood cancer, but in most cases it actually starts from the Lymph glands. We have different Lymph glands in our body (in our neck, armpits, chest, abdomen and groin). Whilst Lymphoma tends to start in the Lymph glands, it can occasionally spread to the bone marrow or other organs as well.

Question – What are the signs and symptoms for both Leukaemia and Lymphoma?

MANOS NIKOLOUSIS – Leukaemia usually affects the production of blood cells in the bone marrow. Within bone marrow there are three different types of cells; the red cells which carry oxygen to different tissues, the white cells which fight infection, and platelets which prevent bleeding and form a blood clot when we have a wound. When a patient gets Leukaemia, all three different cell lines can get affected at the same time.

Therefore the symptoms can be tiredness (because of the reduction of red blood cells), infections (because of the under production of and low quality of white blood cells) and bleeding problems in the form of bruising around the body or nose/mouth bleeds.

With Lymphoma, this is slightly different. You might not have any symptoms, or you might notice symptoms including a swelling around the neck, night sweats or weight loss. If the Lymphoma has spread to the bone marrow, symptoms can be similar to leukaemia.

With both these conditions, patients can get tiredness and often describe their condition as feeling under the weather. Until the tests are done, it is hard to diagnose the symptoms, which is why from a clinical perspective it is extremely important to really listen to your patient and try to understand their symptoms when they come to your clinic.

Question – Is the NHS up to speed on cancer patient diagnosis?

MANOS NIKOLOUSIS – We are certainly getting better. This is shown by the amount of blood cancers that are diagnosed per year, which is a gradual increase year by year. We are getting better at diagnosing these blood cancers and also in giving patients the right treatment to get the best outcomes.

Question – Do you think there is room for improvement and if there is how can it be improved?

MANOS NIKOLOUSIS –

There is always room for improvement. Over the last twenty years, there has been a massive improvement in the risk specifications for haematology patients as well as their outcomes. Over the last ten years there are new molecular markers and new prognostic markets for Leukaemia and Lymphomas. We can also identify the patients who are not going to do very well and can identify the best treatments for them. Equally for those who are expected to do better, we can give them less intensive treatment and therefore try to minimise the risks from this. We are much better in offering the patient the best care.

Question – How effective are the treatments in the NHS compared to those in Spain?

MANOS NIKOLOUSIS – I’m not an expert on the Spanish healthcare system. However, over the last three years, the introduction of the cancer trust fund within the NHS means there are more efficient drugs and more treatments available here than in other European countries. The NHS is one of the healthcare organisations where clinical trials are important, which enables the novel drugs. It also allows us to see whether certain treatments work better than previous treatments.

Esther from Leukaemia Care

Question – What are your major criticisms of Cancer policy in the UK?

ESTHER WROUGHTON – Nationally, there are a lot of questions about cancer policy in the UK with the cancer reforms and cancer policy. I think that will become apparent throughout our news channels and we will find out a bit more about this throughout the year.

Question – Why do people use the internet for diagnosis?

ESTHER WROUGHTON – We all use the internet to search for things whether it be for shopping or to look up symptoms.

Leukaemia Care conducted a survey which highlighted that 85% of the population go online to look up their symptoms and that there is a trend to self-diagnose and to get support online. When searching for information about symptoms on the internet, there is a risk of putting two and two together and coming out with five or mistakenly thinking that your condition is less serious than it actually is and not getting prompt medical attention.

Therefore, we are launching the ‘Call On Us’ campaign to highlight the importance of talking to somebody, picking up the phone and making a call. The internet certainly has its place; it is great for getting factual generic information but it is not specific to the individual and it can’t give you that personal touch and ask how you’re feeling today. Symptoms may be different day to day. Plus the impact of a blood cancer can affect not just the patient but carers and family members as well.

Question – Do you think that one of the reasons people are self-diagnosing is to do with massive wait times at GP surgeries?

ESTHER WROUGHTON – Potentially, I think that’s a good point but I also think that when we are at home in the evenings we can easily use our iPad, our mobile phones and digital devices. It’s important to be aware that you are not getting specific tailored information.

Question – Do you think that people are not picking up the phone because they don’t want to relay personal details to someone they do not know at the other end of the line?

ESTHER WROUGHTON – Everybody is different. Some people prefer talking to someone on the phone whilst others prefer sending an email or accessing our live chat online service. The recent survey showed that 54% of blood cancer patients are kept awake at night worrying that they were going to die, whilst 63% worry about whether their diagnosis would progress more quickly and how that would affect their family members.

I think initially people can be worried about picking up the phone but once they do ring our Care Line they find they are speaking to an expert; someone who knows what they are going through, someone who has been there themselves or are a carer of somebody who actually has a blood cancer. The feedback about the Care Line is that people do find it an invaluable service; they can be put at ease and find it valuable to have one to one contact which really does relay their fears when they get that appropriate advice.

Question – What advice do you give to somebody with leukaemia?

ESTHER WROUGHTON – Pick up the phone and call our Care Line. It is like having a conversation with your friend and you will get that personal touch. They will ask how are you feeling today, is your diagnosis affecting your work, do you need financial assistance, do you need more appropriate medical advice or more information on your diagnosis?

After visiting the hospital or the G.P. patients can often have questions they’ve forgotten to ask or perhaps they didn’t take on board all the information given to them. They can have questions in the middle of the night, in the evening or when they wake up. The Care Line allows patients and carers to ask those questions and we are available 24 hours a day 7 days a week.

Do you have blood cancer and live in the USA? In which case you might qualify for $125 for taking part in an interview!


Blood Cancer research

Blood Cancer research

Our friends at M3 Global Research have used us to help them find people to help them with some research in America.

They are interested in people who wish talk about the unmet needs of people with blood cancer, the factors that may motivate a person to talk to his/her doctor about a new treatment and how people want to receive information about new treatment options. They are very interested in listening to their perspectives and thoughts on a series of messages, as the insights you can provide will help them understand how to improve information given to people about new treatments. The results of the research will be used to help provide patients the information necessary to make a treatment decision that is best for them.

They are offering $125 to the patients who successfully complete the interview, which will last for 60 minute over the telephone. They are looking to conduct interviews with the patients in the weeks of 8th and 15th of December.

There is some criteria you will need to meet to qualify, this is as follows:

• You will need to be 18 years of age or older
• Live in the USA
• Diagnosed with Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukaemia (CLL)
• Be on current treatment/ in-between treatments or have discontinued treatment
• Have access to a computer/ laptop/ tablet with working internet for the interview

If you would like to take part please call Juli Finney 610-952-6176. Alternatively you can email her email her at jfinney@usa.m3.com.

Thanks very much in advance.


Blood Cancer Awareness Month – please share this brilliant infographic from Leukemia and Lymphoma Society


This month is National Blood Cancer Awareness Month promoted by the Leukemia and Lymphoma Society.

The have produced a brilliant infographic below. Please do share to help us raise awareness of blood cancers such as Leukemia and Lymphoma.

National Blood Cancer Awareness Month

National Blood Cancer Awareness Month